FY27 revenue growth of 15-20%
Management expects top line to grow 15-20% in FY27, driven by continued momentum in cotton, paddy, and maize.
NATHBIOGENES / guidance tracker
Keep management guidance in view.
Nath Bio-Genes · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
revenue
EBITDA and PAT margins to trend slightly upward
Management guided for EBITDA and PAT margins to maintain a slightly upward trend, with PAT margin expected to improve by 1-1.5% over FY26 levels.
Minimal capex; focus on rental infrastructure
No major capex planned for processing or storage; company prefers renting to avoid underutilization.